LSV Asset Management
CVS icon

LSV Asset Management’s CVS Health CVS Stock Holding History

LSV Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323M Sell
4,503,497
-37,155
-0.8% -$2.86M 0.7% 34
2025
Q4 		$360M Sell
4,540,652
-78,409
-2% -$6.18M 0.79% 26
2025
Q3 		$348M Sell
4,619,061
-143,735
-3% -$9.85M 0.77% 26
2025
Q2 		$329M Sell
4,762,796
-284,190
-6% -$18.6M 0.77% 29
2025
Q1 		$342M Sell
5,046,986
-357,100
-7% -$21.4M 0.82% 24
2024
Q4 		$243M Sell
5,404,086
-289,490
-5% -$16.2M 0.56% 56
2024
Q3 		$358M Sell
5,693,576
-152,525
-3% -$8.9M 0.77% 31
2024
Q2 		$345M Sell
5,846,101
-91,700
-2% -$5.74M 0.76% 27
2024
Q1 		$474M Sell
5,937,801
-27,086
-0.5% -$2.07M 0.98% 12
2023
Q4 		$471M Buy
5,964,887
+275,512
+5% +$19.6M 1.03% 9
2023
Q3 		$397M Sell
5,689,375
-79,916
-1% -$5.66M 0.92% 15
2023
Q2 		$399M Buy
5,769,291
+24,247
+0.4% +$1.73M 0.88% 19
2023
Q1 		$427M Buy
5,745,044
+170,561
+3% +$14.3M 0.96% 14
2022
Q4 		$519M Sell
5,574,483
-195,583
-3% -$18.9M 1.15% 9
2022
Q3 		$550M Buy
5,770,066
+63,102
+1% +$6.25M 1.29% 6
2022
Q2 		$529M Sell
5,706,964
-208,514
-4% -$20.4M 1.14% 7
2022
Q1 		$599M Sell
5,915,478
-33,021
-0.6% -$3.47M 1.1% 8
2021
Q4 		$614M Sell
5,948,499
-232,713
-4% -$21.5M 1.09% 9
2021
Q3 		$525M Sell
6,181,212
-198,547
-3% -$16.6M 0.95% 14
2021
Q2 		$532M Sell
6,379,759
-27,888
-0.4% -$2.28M 0.91% 16
2021
Q1 		$482M Sell
6,407,647
-574,360
-8% -$41.8M 0.82% 23
2020
Q4 		$477M Sell
6,982,007
-248,343
-3% -$16.2M 0.87% 21
2020
Q3 		$422M Buy
7,230,350
+80,342
+1% +$5M 0.86% 22
2020
Q2 		$465M Buy
7,150,008
+960,996
+16% +$60.5M 0.96% 20
2020
Q1 		$367M Buy
6,189,012
+2,724,991
+79% +$182M 0.89% 23
2019
Q4 		$257M Buy
3,464,021
+1,692,449
+96% +$119M 0.4% 78
2019
Q3 		$112M Buy
1,771,572
+88,107
+5% +$5.22M 0.18% 154
2019
Q2 		$91.7M Buy
1,683,465
+633,397
+60% +$34.1M 0.15% 179
2019
Q1 		$56.6M Sell
1,050,068
-265,563
-20% -$16.4M 0.09% 225
2018
Q4 		$86.2M Buy
1,315,631
+871,631
+196% +$65.1M 0.15% 170
2018
Q3 		$35M Sell
444,000
-9,400
-2% -$672K 0.05% 298
2018
Q2 		$29.2M Sell
453,400
-2,200
-0.5% -$145K 0.05% 315
2018
Q1 		$28.3M Sell
455,600
-396,257
-47% -$28.4M 0.05% 313
2017
Q4 		$61.8M Sell
851,857
-5,211,998
-86% -$379M 0.1% 221
2017
Q3 		$493M Buy
6,063,855
+1,180,964
+24% +$93.4M 0.81% 19
2017
Q2 		$393M Buy
4,882,891
+302,975
+7% +$23.9M 0.7% 27
2017
Q1 		$360M Buy
4,579,916
+1,404,384
+44% +$112M 0.66% 34
2016
Q4 		$251M Buy
3,175,532
+2,451,507
+339% +$198M 0.46% 64
2016
Q3 		$64.4M Buy
724,025
+243,430
+51% +$23M 0.13% 177
2016
Q2 		$46M Buy
480,595
+122,725
+34% +$12.2M 0.09% 209
2016
Q1 		$37.1M Buy
357,870
+28,500
+9% +$2.77M 0.08% 220
2015
Q4 		$32.2M Buy
329,370
+25,700
+8% +$2.52M 0.07% 232
2015
Q3 		$29.3M Sell
303,670
-1,258,530
-81% -$132M 0.07% 232
2015
Q2 		$164M Sell
1,562,200
-87,180
-5% -$8.91M 0.34% 100
2015
Q1 		$170M Sell
1,649,380
-1,182,930
-42% -$120M 0.35% 96
2014
Q4 		$273M Sell
2,832,310
-2,432,120
-46% -$214M 0.57% 61
2014
Q3 		$419M Sell
5,264,430
-315,030
-6% -$24.8M 0.92% 23
2014
Q2 		$421M Sell
5,579,460
-174,310
-3% -$13.2M 0.93% 22
2014
Q1 		$431M Sell
5,753,770
-242,616
-4% -$17.1M 1% 18
2013
Q4 		$429M Sell
5,996,386
-173,861
-3% -$11.2M 1.01% 18
2013
Q3 		$350M Sell
6,170,247
-44,050
-0.7% -$2.62M 0.9% 20
2013
Q2 		$355M Buy
+6,214,297
New +$360M 0.95% 19

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSV Asset Management's CVS Position: Q1 2026 in Review

LSV Asset Management reduced its CVS Health (CVS) stake by 0.82% in Q1 2026, selling an estimated $2.86M and leaving 4,503,497 shares worth $323M. The position accounts for 0.7% of the portfolio, ranked #34.

LSV Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $614M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • LSV Asset Management held 4,503,497 shares of CVS Health worth $323M as of Q1 2026.
  • LSV Asset Management sold 37,155 CVS Health shares in Q1 2026, an estimated $2.86M.
  • CVS Health made up 0.7% of LSV Asset Management's portfolio in Q1 2026, its #34 holding.
  • LSV Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • LSV Asset Management's CVS Health position peaked at $614M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.